PAL inhibitors, or phenylalanine ammonia-lyase (PAL) inhibitors, are a class of compounds that interfere with the activity of the enzyme phenylalanine ammonia-lyase, which plays a crucial role in the phenylpropanoid biosynthetic pathway. PAL catalyzes the deamination of L-phenylalanine to trans-cinnamic acid and ammonia, a reaction that represents the first step in the conversion of phenylalanine to various aromatic compounds, including lignin, flavonoids, and other secondary metabolites in plants. This pathway is integral to the formation of complex organic molecules that contribute to plant structure, pigmentation, and defense mechanisms. PAL inhibitors, by impeding this process, can alter the production of these metabolites, leading to significant changes in the physiological and biochemical properties of the organism. These changes might include variations in the synthesis of lignin and other phenylpropanoid compounds that are essential to the structural integrity and adaptability of plants.
From a mechanistic standpoint, PAL inhibitors function by binding to the active site of the enzyme or by altering its conformation, rendering it less effective or inactive. Inhibitors can be naturally occurring compounds or synthetically produced molecules designed to mimic the substrate or transition states within the enzymatic reaction. Structural studies on PAL and its inhibitors have revealed the importance of specific residues within the enzyme's active site, which facilitate substrate binding and catalysis. Additionally, the inhibition of PAL can have downstream effects on a variety of interconnected metabolic pathways, affecting not only phenylpropanoid biosynthesis but also general carbon and nitrogen metabolism. As PAL plays a key role in linking primary and secondary metabolism in plants, its inhibition can serve as a tool for studying metabolic regulation and phenotypic plasticity under various environmental conditions.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB is commonly used as an agent that affects IP3 receptors and TRP channels. It can influence calcium signaling, which plays a role in the mGluR6 pathway that could possibly affect PAL activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a compound that affects tyrosine kinases. As tyrosine kinases can modulate several signaling pathways, including the mGluR6 pathway, this compound could possibly affect PAL activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride is known to affect glycogen synthase kinase 3 (GSK3). By having an effect on the GSK3 pathway, this compound could possibly affect mGluR6 signaling and PAL's activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent agent that affects phosphoinositide 3-kinases (PI3K). It can disrupt PI3K signaling, which could possibly have an effect on the mGluR6 pathway and PAL's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another agent that affects PI3K. This compound could possibly influence the mGluR6 pathway and PAL's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a selective compound that affects MEK, a kinase involved in various signaling pathways. This compound could possibly influence the mGluR6 pathway and PAL's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB202190 is a potent agent that affects p38 MAPK. It can disrupt MAPK signaling, which could possibly affect the mGluR6 pathway and PAL's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a compound that affects JNK, which is involved in several signaling pathways. By affecting JNK, this compound could possibly influence the mGluR6 pathway and PAL's activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a compound that affects Rho-associated protein kinases (ROCK). It can disrupt ROCK signaling, which could possibly affect the mGluR6 pathway and PAL's activity. |